Skinvisible, Inc. (SKVI)
OTCMKTS · Delayed Price · Currency is USD
0.2000
0.00 (0.00%)
Jul 17, 2026, 3:47 PM EST
Skinvisible Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | 0 | 0.01 | 0 | 0.08 | 0.07 |
Cash & Short-Term Investments | 0 | 0 | 0.01 | 0 | 0.08 | 0.07 |
Cash Growth | -86.58% | -74.65% | 1063.96% | -98.91% | 23.23% | 83.97% |
Accounts Receivable | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Other Receivables | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | - |
Receivables | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0 |
Prepaid Expenses | - | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Current Assets | 0.02 | 0.03 | 0.04 | 0.04 | 0.11 | 0.07 |
Other Intangible Assets | 0.1 | 0.1 | 0.12 | 0.13 | 0.14 | 0.15 |
Total Assets | 0.12 | 0.13 | 0.16 | 0.16 | 0.25 | 0.23 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.35 | 1.25 | 0.86 | 0.44 | 1.2 | 1.04 |
Accrued Expenses | 3.5 | 3.36 | 2.78 | 2.58 | 1.96 | 1.48 |
Short-Term Debt | 0.41 | 0.4 | 0.01 | 0.05 | 0.04 | 0.07 |
Current Portion of Long-Term Debt | 0.01 | 0.01 | - | 0.43 | 0.43 | 0.43 |
Other Current Liabilities | - | - | - | 0.02 | 0.01 | 0.05 |
Total Current Liabilities | 5.28 | 5.02 | 3.66 | 3.51 | 3.64 | 3.06 |
Long-Term Debt | 5.37 | 5.37 | 5.72 | 5.67 | 3.24 | 2.58 |
Other Long-Term Liabilities | - | - | - | - | - | -0 |
Total Liabilities | 10.65 | 10.39 | 9.38 | 9.19 | 6.89 | 5.64 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
Additional Paid-In Capital | 30.74 | 30.74 | 30.71 | 30.35 | 30.35 | 30.35 |
Retained Earnings | -41.28 | -41.01 | -39.95 | -39.38 | -37 | -35.77 |
Comprehensive Income & Other | - | - | 0.01 | - | - | - |
Shareholders' Equity | -10.53 | -10.26 | -9.22 | -9.02 | -6.64 | -5.42 |
Total Liabilities & Equity | 0.12 | 0.13 | 0.16 | 0.16 | 0.25 | 0.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5.8 | 5.78 | 5.74 | 6.15 | 3.72 | 3.08 |
Net Cash (Debt) | -5.79 | -5.78 | -5.73 | -6.15 | -3.63 | -3.02 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.07 | -1.07 | -1.13 | -1.36 | -0.80 | -0.66 |
Filing Date Shares Outstanding | 5.4 | 5.4 | 5.32 | 4.54 | 4.54 | 4.54 |
Total Common Shares Outstanding | 5.4 | 5.4 | 5.32 | 4.54 | 4.54 | 4.54 |
Working Capital | -5.25 | -4.99 | -3.62 | -3.48 | -3.54 | -2.99 |
Book Value Per Share | -1.95 | -1.90 | -1.73 | -1.99 | -1.46 | -1.19 |
Tangible Book Value | -10.62 | -10.36 | -9.34 | -9.15 | -6.78 | -5.57 |
Tangible Book Value Per Share | -1.97 | -1.92 | -1.76 | -2.02 | -1.49 | -1.23 |